Ergomed targets expansion into Asia with necessary ‘firepower’ for M&As
The company said its EBITDA will be ahead of current market expectations in its report today
Company
Ergomed PLC
LON:ERGO
Ergomed PLC provides specialist services to the pharmaceutical industry spanning all phases of clinical development, post-approval pharmacovigilance and medical information. The company's fast-growing services business includes an industry-leading suite of specialist pharmacovigilance (PV) solutions, integrated under the PrimeVigilance brand and a full range of high-quality clinical research and trial management services under the Ergomed brand (CRO).
204 stories · page 2 of 11
Ergomed shares jump 9% after better-than-expected trading update; broker bullish
Peel Hunt, the company’s joint broker, said it has been impressed by the 2021 numbers, “especially given the foreign exchange headwinds for the majority of the year”
Ergomed says its earnings will beat market expectations; co "extremely confident" about the future
The growth of the US business the stand-out feature of the company’s performance
Ergomed confident on outlook after strong interim results
Total revenue climbed 39% to £56mln, with adjusted underlying earnings (EBITDA) up 33% to £12mln
Ergomed sees exceptional first half performance
"Ergomed has delivered exceptional results and operational progress during the first half of the year,” said executive chair Dr Miroslav Reljanović.
Ergomed senior independent director to step down
The company said Rolf Soderstrom has decided to step down to focus on other business activities but will remain on the board until September 30 to provide a period of transition
Ergomed sees earnings ahead of expectations as chairman highlights strong start to 2021
Dr Miroslav Reljanović says the pharma services firm has built on the momentum of 2020 and made a strong start to the current year.
Ergomed appoints Shire's former head of corporate development as a non-exec
Mark Enyedy is currently chief executive of Nasdaq-listed ImmunoGen
Ergomed opens PrimeVigilance business in Japan
The Japanese pharmaceutical market is the fourth-largest in the world after the US, the EU and China
Ergomed in strong position after storming performance in 2020
In 2020 there was a strong operational and financial performance from both of the group's businesses, Pharmacovigilance (PV) and Clinical Research Services (CRO), the company said.
Ergomed says 2020 adjusted underlying earnings will be ahead of market expectations
The company said the outlook for 2021 is positive, bolstered by the strong order book and the acquisitions of Ashfield PV and MedSource.
Ergomed gains as it expands its US footprint in earnings enhancing deal worth up to US$25mln
Chairman, Dr Miroslav Reljanović, said the addition of MedSource builds on the successful acquisition and integration of Ashfield Pharmacovigilance, now PrimeVigilance USA, earlier this year
Ergomed confident of continued momentum after exceptional first half
"Ergomed has delivered exceptional progress both operationally and financially during the first half of the year,” said Miroslav Reljanović, the group's executive chairman
Ergomed says full-year earnings to be “materially ahead of market expectations”
The group, which provides services to the pharma industry such as contract research and drug monitoring, gave the update after assessing its first-half performance
Archive
Proactive news headlines: e-therapeutics, Ergomed, Metal Tiger, Tower Resources …
A glance at some of the day's highlights from the Proactive Investors newswire
Ergomed executive chairman says firm “had a good first quarter, with solid overall growth in revenue”
Dr Miroslav Reljanović added: “At this time the Company is confident that results will be in line with current market expectations for the 2020 financial year”
Ergomed’s PrimeVigilance inks collaboration deal to accelerate intelligent automation strategy
The partnership with Automation Anywhere and DataRobot is expected to deliver organic growth more efficiently with the automation of manual, repetitive processes
Archive
Ergomed to help run second trial in Italy targeting possible coronavirus treatments
The programme is being conducted at the Humanitas Research Hospitals in Bergamo and Milan
Ergomed highlights first data from coronavirus study at Bergamo in Italy
Ergomed is providing clinical development and research services including significant involvement in the study's design and implementation
Ergomed's PrimeVigilance supports coronavirus trial
The company is providing the services through its specialist pharmacovigilance provider as part of an ongoing clinical trial